
Antidepressants, Agent Orange, and CBD Trial Findings
Which treatments help, and which risks deserve closer attention? Dr. Chi-Ming Chow reviews a comparison of 20 antidepressants, evidence linking Agent Orange exposure to twice the risk of Parkinson’s disease among veterans, and a trial finding CBD no better than placebo for severe behavioral problems in children with intellectual disabilities.
Key Points
- A large comparative study suggests escitalopram, duloxetine, and agomelatine may be more effective than fluoxetine for treating depression and helping prevent relapse, but antidepressant choice still needs to be individualized.
- Veterans exposed to Agent Orange had a higher risk of Parkinson’s disease, reinforcing concerns about long-term neurologic effects of toxic herbicide exposure and the need for continued support and surveillance.
- CBD did not outperform placebo for severe behavioral problems in children with intellectual disabilities, underscoring the importance of evidence-based treatment decisions and caution with unproven therapies.
Chapters
| 0:00 | |
| 3:07 | |
| 9:36 |
Transcript
Loading transcript...
- / -

